ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 303

The Value of the Simplified Ramris-5 in Early RA Patients Under Methotrexate Therapy Using High Field MRI

Philipp Sewerin1, Miriam Frenken2, Daniel Benjamin Abrar2, Christine Goertz3, Christoph Schleich4, Matthias Schneider5 and Benedikt Ostendorf1, 1Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, 2Department for diagnostic and interventional Radiology, Heinrich-Heine-Universitiy, Duesseldorf, Germany, 3Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine-Universitiy, Duesseldorf, Germany, 4Department for diagnostic and interventional Radiology, Heinrich-Heine University, Duesseldorf, Germany, 5Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Imaging, MRI and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Imaging of Rheumatic Diseases Poster I: MRI

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of the study was to evaluate a simplified version of the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) to five joints of the hand (RAMRIS-5) in patients with early rheumatoid arthritis (RA) before and after the initiation of a methotrexate (MTX) therapy using high-resolution, 3 Tesla (T), magnetic resonance imaging (MRI).

Methods: 28 RA patients according to 2010 ACR/EULAR criteria (Ø 56.8 years (range 39 – 74), seropositive, disease duration < 6 months (range 2 – 23 weeks) were prospectively assessed with baseline investigation including clinical assessment (DAS-28 and CRP) and 3T MRI of the clinical dominant hand, as well as 3 and 6 months after starting MTX therapy. MRI-scans were analysed according to RAMRIS and the simplified RAMRIS-5 (Figure-1).

Results: DAS-28, CRP, RAMRIS and RAMRIS-5 decreased significantly after initiation of a MTX therapy. There was a strong correlation between RAMRIS-5 and RAMRIS at baseline (r=0.838; p=˂0.001) and follow-up (3 months: r=0.876; p= ˂0.001; 6 months: r=0.897; p=˂0.001).

Conclusion: 3T MRI based RAMRIS-5, a simplified and resource-saving RAMRIS score is a suitable tool to show changes in early RA and may be used for diagnosis and therapy monitoring in follow-up evaluations.

Figure1


Disclosure: P. Sewerin, None; M. Frenken, None; D. B. Abrar, None; C. Goertz, None; C. Schleich, None; M. Schneider, None; B. Ostendorf, None.

To cite this abstract in AMA style:

Sewerin P, Frenken M, Abrar DB, Goertz C, Schleich C, Schneider M, Ostendorf B. The Value of the Simplified Ramris-5 in Early RA Patients Under Methotrexate Therapy Using High Field MRI [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-value-of-the-simplified-ramris-5-in-early-ra-patients-under-methotrexate-therapy-using-high-field-mri/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-value-of-the-simplified-ramris-5-in-early-ra-patients-under-methotrexate-therapy-using-high-field-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology